Stock Surge: Travere Therapeutics Inc (TVTX) Closes at 18.81, Marking a 0.59 Increase/Decrease

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Travere Therapeutics Inc (NASDAQ: TVTX) closed at $18.81 up 0.59% from its previous closing price of $18.70. In other words, the price has increased by $0.59 from its previous closing price. On the day, 1.49 million shares were traded. TVTX stock price reached its highest trading level at $19.13 during the session, while it also had its lowest trading level at $18.68.

Ratios:

For a deeper understanding of Travere Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.68 and its Current Ratio is at 1.71.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on October 21, 2024, Upgraded its rating to Overweight and sets its target price to $27 from $9 previously.

Guggenheim Upgraded its Neutral to Buy on September 09, 2024, while the target price for the stock was maintained at $25.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 25 ’24 when Calvin Sandra sold 12,090 shares for $18.30 per share. The transaction valued at 221,258 led to the insider holds 54,927 shares of the business.

Calvin Sandra bought 12,090 shares of TVTX for $221,258 on Nov 25 ’24. On Oct 04 ’24, another insider, LYONS GARY A, who serves as the Director of the company, sold 40,000 shares for $14.73 each. As a result, the insider received 589,101 and left with 51,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1637115264 and an Enterprise Value of 1593114112. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.09. Its current Enterprise Value per Revenue stands at 7.831 whereas that against EBITDA is -6.673.

Stock Price History:

Over the past 52 weeks, TVTX has reached a high of $20.33, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 9.88%, while the 200-Day Moving Average is calculated to be 80.54%.

Shares Statistics:

For the past three months, TVTX has traded an average of 1.96M shares per day and 1221180 over the past ten days. A total of 87.03M shares are outstanding, with a floating share count of 85.72M. Insiders hold about 1.51% of the company’s shares, while institutions hold 97.29% stake in the company. Shares short for TVTX as of 1731628800 were 6971485 with a Short Ratio of 3.56, compared to 1728950400 on 8107720. Therefore, it implies a Short% of Shares Outstanding of 6971485 and a Short% of Float of 8.870000000000001.

Most Popular